GENERAL INFORMATION

   Advanced Partners:

Medical Research Council, Human Genetics Unit, University of Edinburgh (UEDIN), Great Britain – combines scientific and clinical expertise to study human genetic disease and normal development. UEDIN supports the IIMCB in broadening its scientific scope by training its researchers. It also engages in enhancing the IIMCB methodological capabilities through the development of modern core facilities and upgrading IIMCB science management.



Flanders Institute of Biotechnology (VIB), Belgium is an entrepreneurial research institute that is a European leader in translational research. VIB supports the IIMCB in creating a Technology Transfer Office and training researcher staff. It also helps the IIMCB in developing modern core facilities and science management and administration. The partnership between the IIMCB and VIB is boosted by the supportive culture of excellence within the EU-LIFE alliance.

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.

Dr. Wojciech Pokrzywa, Postdoc Dr. Abhishek Dubey, and Ph.D. student Natalia Szulc, members of the GRIEG project, actively participated in the 24th International C. elegans Conference in Glasgow, June 24-28, 2023. In this largest gathering dedicated to worm research, the group presented posters on two distinct subjects.

Firstly, they shared their research on the intriguing cold resistance effect induced by 5'-fluorodeoxyuridine (FUdR), an anticancer drug, in C. elegans. Their findings shed light on the potential applications of FUdR in enhancing the organism's ability to withstand low temperatures. The team's presentation on this topic captivated the attention of the conference attendees, leading to engaging and fruitful discussions.

Furthermore, the group showcased their significant discoveries regarding an ultra-rare mutation found in the FEM1C gene, which gives rise to a severe neurodevelopmental disorder. The impact of their research on understanding the underlying mechanisms of this disorder garnered considerable interest from the conference participants.

In addition, the scientists had the opportunity to meet their collaborators on the GRIEG grant – the group of Prof. Rafał Ciosk from the University of Oslo. The researchers discussed the progress and advancements of their ongoing joint projects while also planning and strategizing for upcoming experiments.

Overall, the participation of the Laboratory of Protein Metabolism at the 24th International C. elegans Conference in Glasgow proved to be highly impactful, not only through their research presentations but also through the valuable connections and collaborations they formed with fellow scientists in the field.

The GRIEG project "Cellular adaptation to cold" (CellCOLD), National Science Center, funded by the Norwegian Financial Mechanism 2014-2021.

{gallery}24th International C. elegans Conference{/gallery}

Prof. Wojciech Pokrzywa participated in the Second Congress of the We Are Against the Wall Foundation "Rare diseases - a look from many perspectives" on 16-17.06.2023 in Krakow with a presentation entitled " Personalizacja terapii chorób rzadkich: nicień C. elegans w badaniach naukowych i rozwoju przyszłych metod leczenia".

Presentation was carried out within the framework of the GRIEG project "Cellular adaptation to cold" (CellCOLD), National Science Center, funded by the Norwegian Financial Mechanism 2014-2021.

{gallery}Prof. Wojciech Pokrzywa participated in the Second Congress of the We Are Against the Wall Foundation{/gallery}

 Z przyjemnością prezentujemy Państwu Raport Roczny Międzynarodowego Instytutu Biologii Molekularnej i Komórkowej za 2022 rok. Zapraszamy do lektury!

W poniedziałek 27 marca odbyły się warsztaty edukacyjne w Międzynarodowym Instytucie Biologii Molekularnej i Komórkowej w Warszawie. Gościliśmy uczniów z XXI Liceum Ogólnokształcącego im. Hugona Kołłątaja. Podczas warsztatów mogli oni poznać historię Instytutu, wysłuchać wykładu na temat krystalizacji białek oraz zwiedzić wybrane laboratoria. Uczniowie odwiedzili również laboratoria prowadzone przez prof. dr hab. Andrzeja Dziembowskiego i dr hab. Wojciecha Pokrzywę; dowiedzieli się o badaniach prowadzonych w IIMCB w dwóch projektach Griega oraz w projekcie MOSaIC. Wielkie podziękowania dla wszystkich naszych gospodarzy: dr Romana Szczepanowskiego, dr Krzysztofa Skowronka, prof. dr hab. Marcina Nowotnego, prof. dr hab. Andrzeja Dziembowskiego i dr hab. Wojciecha Pokrzywy za podzielenie się swoją pasją!

{gallery}GRIEG Educational workshops{/gallery}

On Monday, March 27 an educational workshops were held at the International Institute of Molecular and Cell Biology in Warsaw. We hosted pupils from the 21st Hugo Kołłątaj High School. During the workshops they could learn about the history of the institute, listened to a lecture on protein crystallization and visted selected laboratories and core facilities. Pupils also visited the laboratories led by prof. dr hab. Andrzej Dziembowski and dr hab. Wojciech Pokrzywa; they learned about the research carried at the IIMCB in two Grieg projects and in the MOSaIC project as well.

Great thanks to all our hosts: dr Roman Szczepanowski, dr Krzysztof Skowronek, prof.dr hab. Marcin Nowotny, prof. dr hab. Andrzej Dziembowski and dr hab.Wojciech Pokrzywa for sharing their passion!

{gallery}GRIEG Educational workshops{/gallery}

Warszawska Szkoła Doktorska Nauk Przyrodniczych i BioMedycznych (Warsaw-4-PhD) została utworzona pomiędzy 9 warszawskimi jednostkami naukowymi na podstawie porozumienia podpisanego 2 kwietnia 2019 r. Pierwszych doktorantów powitaliśmy w październiku 2019 roku. Od początku istnienia oferujemy interdyscyplinarne kształcenie w 4 dyscyplinach naukowych: biologii, chemii, fizyce i medycynie.

Warszawska Szkoła Doktorska Nauk Ścisłych i BioMedycznych  
| 9 jednostek naukowych | 4 dyscypliny |

Nencki

MIBMiK

Inne

W dniu 19 września 2022 Prof. A.Dziembowski wystąpił z prezentacją naukową w NIH RNA Biology Laboratory. Wystąpienie było zatytułowane „Ribonucleases and poly(A) polymerases in cancer and other diseases".